| | 220127-57-1 Basic information More.. |
| Product Name: | Imatinib mesylate | | Synonyms: | 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide;Imatinib mesylate / 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;Gleevec (Imatinib);IMatinib Mesylate(STI-571);Gleevec, Glivec, CGP-57148B, STI-571;4-[(4-Methyl-1-piperazinyl)Methyl]-N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]phenyl]benzaMide Methanesulfonate;IMATINIB METHANESULFONATE;CGP-57148B | | CAS: | 220127-57-1 | | MF: | C30H35N7O4S | | MW: | 589.71 | | EINECS: | 606-892-3 | | Mol File: | 220127-57-1.mol |  |
Use
Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.
As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.
- Imatinib Mesylate
-
- US $650.00-350.00 / KG
- 2024-05-23
- CAS:220127-57-1
- Min. Order: 1KG
- Purity: High Density
- Supply Ability: 20 tons
- Imatinib mesylate
-
- US $0.00-0.00 / kg
- 2024-05-09
- CAS:220127-57-1
- Min. Order: 1kg
- Purity: 99.9%(HPLC)
- Supply Ability: 10 tons
- Imatinib mesylate
-
- US $33.00-1.20 / kg
- 2024-04-27
- CAS:220127-57-1
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: g-kg-tons, free sample is available
|
|
220127-57-1
Recommend Suppliers |
|